Subsequent experiments revealed that silencing of FASN decreases HCC cell growth and increases apoptosis in vitro, and ablation of FASN completely suppresses AKT and AKT/c-Met driven HCC formation in mice [25,30]. Here, FASN is linked to hepatocellular carcinoma.